Hostname: page-component-76d6cb85b7-f97m6 Total loading time: 0 Render date: 2026-07-24T18:05:30.849Z Has data issue: false hasContentIssue false
  • English
  • Français

Rationale and use of n-3 fatty acids in artificial nutrition – Corrigendum

Published online by Cambridge University Press:  20 January 2011

Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the ‘Save PDF’ action button.

Information

Type
Corrigendum
Information
Proceedings of the Nutrition Society , Volume 70 , Issue 2 , May 2011 , pp. 282
Copyright
Copyright © The Author 2011

On page 567 (column 1, lines 26–27) incorrect information about the EPA plus DHA content of Lipoplus is given.(Reference Calder1)

The information provided (0·6 g per 100 ml) was calculated based upon the EPA and DHA contents of a standard fish oil. However Lipoplus contains more concentrated marine n-3 fatty acids as reported by Driscoll et al.(Reference Driscoll, Ling and Bistrian2) Therefore the statement should read:

Each 100 ml of Lipoplus will typically contain about 1·2 g EPA plus DHA.

References

1.Calder, PC (2010) Rationale and use of n-3 fatty acids in artificial nutrition. Proc Nutr Soc 69, 565–573.CrossRefGoogle ScholarPubMed
2.Driscoll, DF, Ling, PR, Bistrian, BR (2009) Pharmacopeial compliance of fish oil-containing parenteral lipid emulsion mixtures: Globule size distribution (GSD) and fatty acid analyses. Int J Pharmaceut 379, 125–130.Google Scholar